Journal of Clinical & Experimental Immunology(JCEI)
ISSN: 2475-6296 | DOI: 10.33140/JCEI
Impact Factor: 1.9
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Mesenchymal stem cells-derived Extracellular Vesicles: A Promising COVID-19 Therapy?
Abstract
Manoj Kumar, Aditya Saini, Sunil Hinduja and Sanjeev Bhoi
Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2). Originated in Wuhan, China in December 2019, COVID-19 soon spread all around the world [1]. As per the WHO, till 4th August 2021, Globally, 200,174,883 confirmed cases of COVID-19, including 4,255,892 deaths and 3,984,596,440 vaccine doses have been administered [2].